Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Quotient Limited Announces Equity Awards
JERSEY, Channel Islands, February 2, 2022 (GLOBE NEWSWIRE) --Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Esteban Uriarte, who has been appointed as the Chief Manufacturing Operations Officer of the…
Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress